HSCSW Company Profile and Key Details

NASDAQ : HSCSW

HeartSciences

$0.05

-0.025-31.29%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

HeartSciences Inc. (HSCSW) stock declined over -31.29%, trading at $0.05 on NASDAQ, down from the previous close of $0.08. The stock opened at $0.06, fluctuating between $0.05 and $0.06 in the recent session.

Stock Snapshot

0.0799

Prev. Close

145.36K

Market Cap

0.0525

Day Low

-0.01

P/E Ratio

-3.85

EPS (TTM)

-0.12

Cash Flow per Share

0.06

Open

2.65M

Number of Shares

0.0571

Day High

N/A

Free Float in %

0.16

Book Value

5.2K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.06	0.06	0.05	0.05	5.2K
Sep 09, 2026	0.08	0.08	0.07	0.08	14.26K
Sep 08, 2026	0.08	0.09	0.08	0.09	44.58K
Sep 04, 2026	0.07	0.07	0.07	0.07	5.01K
Sep 03, 2026	0.05	0.05	0.05	0.05	3
Sep 02, 2026	0.05	0.06	0.05	0.05	6.75K
Sep 01, 2026	0.05	0.05	0.05	0.05	8
Aug 31, 2026	0.04	0.04	0.04	0.04	10
Aug 28, 2026	0.04	0.04	0.04	0.04	7
Aug 27, 2026	0.06	0.06	0.04	0.04	5.09K
Aug 26, 2026	0.05	0.05	0.05	0.05	752
Aug 25, 2026	0.05	0.05	0.04	0.04	608
Aug 24, 2026	0.06	0.06	0.06	0.06	3
Aug 21, 2026	0.04	0.04	0.04	0.04	7
Aug 20, 2026	0.07	0.07	0.04	0.04	10.09K
Aug 19, 2026	0.04	0.04	0.04	0.04	74
Aug 18, 2026	0.04	0.04	0.04	0.04	22
Aug 17, 2026	0.08	0.08	0.08	0.08	3
Aug 14, 2026	0.04	0.04	0.04	0.04	12
Aug 13, 2026	0.04	0.04	0.04	0.04	0

Contact Details

Southlake, TX 76092

United States

https://heartsciences.com 682 237 7781

About Company

Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals. Founded in 2007, the firm's operations are headquartered in Southlake, Texas.

Stock Peers

BRKRP

-11.09-2.73%

Bruker Corporation$395.14 SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

-1.19-0.43%

UFP Technologies, Inc.$277.40 MASI

Masimo Corporation$179.95 ALGN

-2.2-1.44%

Align Technology, Inc.$150.72 PODD

-3.24-2.35%

Insulet Corp.$134.68 IRTC

-6.69-5.60%

iRhythm Technologies, Inc.$112.88 TMDX

-1.36-1.57%

TransMedics Group, Inc.$85.04 DXCM

0.63+0.75%

DexCom, Inc.$84.51 IRMD

-1.69-2.02%

IRadimed Corporation$81.87

Company Overview

HeartSciences Inc. (NASDAQ:HSCSW) closed at $0.05 USD, losing -$0.03 (-31.29%) from the previous close of $0.08. The stock is currently within 5% of its 52-week low $0.05 and $0.07. With a market capitalization of about $145.36 thousand, HeartSciences Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.86). Key stats such as the average daily volume over the past year has been around 2.32 thousand shares, trading with heavier-than-usual volume. Headquartered in Southlake, TX, HeartSciences Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Andrew Simpson, the company employs approximately 14 people and listed since June 15, 2022. Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health.

Technical Performance

HSCSW has shown weak momentum, losing -34.02% over the past week and -58.76% over the past quarter, though year-to-date performance is down -58.76%. Average 10-day trading volume of 9.48 thousand shares is significantly above the 3-month average of 3.44 thousand, indicating heightened recent market interest.

Valuation Metrics

HeartSciences Inc. trades at a P/E ratio of -0.88, slightly below the S&P 500 average, with a price-to-sales ratio of 1715.0 and a price-to-book ratio of 47.98 reflecting a rich premium to book value. The P/FCF stands at -0.99, also above market averages. Compared to sector medians, HeartSciences Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

HeartSciences Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$2.03. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

HeartSciences Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended July 23, 2026, missed forecasts by 0.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 25.4% in July 24, 2025.

Financial & Profitability Overview

Over the trailing twelve months, HeartSciences generated $4.32K in revenue, or $0.00 per share. Gross margin was -2982.15%, operating margin -194787.38%, and net profit margin -211666.47%. Returns are negative, with ROA at -0.17% and ROE at -4.05%.
On valuation metrics, HeartSciences trades at a P/E of -0.88, P/S of 1715.00 and P/B of 47.98. Liquidity is tight, with a current ratio of 0.50 and quick ratio of -134.37. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 924871.77 days. Debt-to-equity is 17.41, supported by a cash flow-to-debt ratio of -1.89.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2025, HeartSciences posted revenue of $4.32K, down slightly from $4.35K in the prior quarter. Gross profit was - $128.80K (margin -2982.15%). Operating income was - $8.41M (margin -194787.4%). Net income was- $9.14M (EPS - $3.48).
The company ended the quarter with $1.66B in cash and short-term investments, a total debt of $3.94B, and net debt of $2.28B. Total assets were $5.26B, with equity of $225.53M. Financials further reflected weakness, with operating cash flow of - $7.43M, free cash flow of - $7.47M, and capital expenditures of - $44.45K.

Price Forecast & Outlook

Our AI price prediction model suggests that HeartSciences Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -27.14%, with price expected at $0.04 by November 24, 2023, within a range of $0.02 to $0.05

Key Takeaways

HeartSciences Inc. (NASDAQ:HSCSW) shares are down -58.76% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows HeartSciences Inc. trading at a premium to the broader market with a P/E of -0.88.

Frequently Asked Questions

What is the current HeartSciences Inc. (HSCSW) stock price?

HeartSciences Inc. (NASDAQ: HSCSW) stock price is $0.05 in the last trading session. During the trading session, HSCSW stock reached the peak price of $0.06 while $0.05 was the lowest point it dropped to. The percentage change in HSCSW stock occurred in the recent session was -31.29% while the dollar amount for the price change in HSCSW stock was - $0.03.

HSCSW's industry and sector of operation?

The NASDAQ listed HSCSW is part of Medical - Devices industry that operates in the broader Healthcare sector. HeartSciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HSCSW?

No Data

How HSCSW did perform over past 52-week?

HSCSW's closing price is 4.57% higher than its 52-week low of $0.05 where as its distance from 52-week high of $0.07 is -23.43%.

How many employees does HSCSW have?

Number of HSCSW employees currently stands at 14.

Link for HSCSW official website?

Official Website of HSCSW is: https://heartsciences.com

How do I contact HSCSW?

HSCSW could be contacted at phone 682 237 7781 and can also be accessed through its website. HSCSW operates from 550 Reserve Street, Southlake, TX 76092, United States.

How many shares of HSCSW are traded daily?

HSCSW stock volume for the day was 5.2K shares. The average number of HSCSW shares traded daily for last 3 months was 2.32K.

What is the market cap of HSCSW currently?

The market value of HSCSW currently stands at $145.36K with its latest stock price at $0.05 and 2.65M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	14
Beta	1.8
Sales or Revenue	$4.32K
5Y Sales Change%	-0.998%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

HSCSW Company Profile and Key Details

HeartSciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Technical Performance

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Valuation Metrics